The Scientist

» open access, immunology and ecology

Most Recent

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

A single receptor on natural killer cells recognizes an amino acid sequence conserved across Zika, dengue, and related pathogens.

0 Comments

image: A Growing Open Access Toolbox

A Growing Open Access Toolbox

By | November 28, 2017

Legal methods to retrieve paywalled articles for free are on the rise, but better self-archiving practices could help improve accessibility. 

0 Comments

image: European Research Council Founder, Molecular Biologist Dies

European Research Council Founder, Molecular Biologist Dies

By | November 20, 2017

Fotis Kafatos, a Greek researcher famous for his work on malaria, has died at age 77.

0 Comments

A team has engineered two stem cell lines into “synthetic T cells” that destroy breast cancer cells in vitro. 

1 Comment

image: ResearchGate Restricts Access to Nearly 2 Million Articles

ResearchGate Restricts Access to Nearly 2 Million Articles

By | November 9, 2017

The academic social network is bending to pressure from publishing giants that demand it removes copyrighted material from its site.

3 Comments

A US judge issues a broad injunction that allows the society to demand that technology companies actively associated with the site block access to it.

3 Comments

image: Tracking Invasive Fire Ants in Asia

Tracking Invasive Fire Ants in Asia

By | November 1, 2017

These insect transplants have the potential to wreak economic havoc by outcompeting native insects and destroying crops.

0 Comments

image: Opinion: Share Your Data

Opinion: Share Your Data

By , , and | October 24, 2017

Our analysis of a collection of open-access datasets quantifies their benefit to the scientific community.

2 Comments

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

Popular Now

  1. Thousands of Mutations Accumulate in the Human Brain Over a Lifetime
  2. Two Dozen House Republicans Do an About-Face on Tuition Tax
  3. Can Young Stem Cells Make Older People Stronger?
  4. Putative Gay Genes Identified, Questioned
    The Nutshell Putative Gay Genes Identified, Questioned

    A genomic interrogation of homosexuality turns up speculative links between genetic elements and sexual orientation, but researchers say the study is too small to be significant. 

FreeShip